- Forecast Update: Evonik raises its FY adjusted Ebitda forecast to EU1.9 billion to EU2.2 billion, up from the previous range of EU1.7 billion to EU2 billion.
- Estimates Compared: The new forecast range includes an estimate of EU2 billion.
- Preliminary Q2 Results: Adjusted Ebitda for the second quarter is preliminarily reported at EU578 million.
- Sales Performance: Preliminary sales for the second quarter are reported to be above EU3.9 billion.
- Key Drivers: Improved results attributed to:
- Strict cost discipline
- Good volume development in Specialty Additives
- Price recovery in Animal Nutrition
- Lower production costs
- Final Q2 Figures: Evonik to publish final figures for Q2 on August 1, 2024.
- Analyst Recommendations: Current analyst ratings include 13 buys, 7 holds, and 1 sell.
A look at Evonik Industries Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Evonik Industries AG, a manufacturer of specialty chemicals, is positioned for a positive long-term outlook based on its Smartkarma Smart Scores. The company excels in providing value and robust dividend returns, scoring high in these areas. Additionally, Evonik demonstrates strong momentum in the market, indicating favorable investor sentiment towards its performance. While the growth and resilience scores are slightly lower, the company’s overall outlook remains promising as it continues to innovate and deliver quality products across various sectors.
In summary, Evonik Industries AG stands out in the specialty chemicals industry for its strong value proposition, attractive dividends, and positive market momentum. With a focus on consumer goods, animal nutrition, and pharmaceuticals, the company is well-positioned to capitalize on future opportunities and maintain its competitive edge in the market. Investors looking for a stable and potentially rewarding long-term investment may find Evonik Industries to be a compelling choice based on its favorable Smartkarma Smart Scores.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
